5α-reduced C21 steroids are substrates for human cytochrome P450c17

被引:78
作者
Gupta, MK
Guryev, OL
Auchus, RJ
机构
[1] Dept Internal Med, Div Endocrinol & Metab, Dallas, TX 75390 USA
[2] UT SW Med Ctr, Dept Biochem, Dallas, TX USA
关键词
17-hydroxylase/17,20-lyase; CYP17; P450c17; androstanediol; allopregnanolone; cytochrome b(5); dihydrotestosterone; 5; alpha-reductase; 3 alpha-hydroxysteroid dehydrogenase; sexual differentiation;
D O I
10.1016/j.abb.2003.07.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Sot-reduction of testosterone in target tissues is a key step in androgen physiology; however, 5alpha-reduced C-19 steroids are sometimes synthesized in testis via a pathway that does not involve testosterone as an intermediate. We studied the metabolism of 5alpha-reduced C-21 steroids by human cytochrome P450c17 (hCYP17), the enzyme responsible for conversion of C-21 steroids to C-19 steroids via its 17alpha-hydroxylase and 17,20-lyase activities. hCYP17 17alpha-hydroxylates 5alpha-pregnan-3,20-dione, but little androstanedione is formed by 17,20-lyase activity. hCYP17 also 17alpha-hydroxylates 5alpha-pregnan-3alpha-ol-20-one and the 5alpha-pregnan-30alpha,17alpha-diol-20-one intermediate is rapidly converted to androsterone by 17,20-lyase activity. Furthermore, 5alpha-pregnan-3alpha,17alpha-diol-20-one is a better substrate for the 17,20-lyase reaction than the preferred substrate 17alpha-hydroxypregnenolone and cytochrome b(5) stimulates androsterone formation only 3-fold. Both 5alpha-pregnan-3alpha-ol-20-one and 5alpha-pregnan-3alpha,17alpha-diol-20-one bind to hCYP 17 with higher affinity than does progesterone. We conclude that 5alpha-reduced, 3alpha-hydroxy-C-21 steroids are excellent, high-affinity substrates for hCYP17. The brisk metabolism of 5alpha-pregnan-3alpha,17alpha-diol-20-one to androsterone by CYP17 explains how, when 5alpha-reductases are present. the testis can produce C-19 steroids androsterone and androstanediol from 17alpha-hydroxyprogesterone without the intermediacy of androstenedione and testosterone. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:151 / 160
页数:10
相关论文
共 51 条
[1]   Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome [J].
Ahmed, SF ;
Cheng, A ;
Dovey, L ;
Hawkins, JR ;
Martin, H ;
Rowland, J ;
Shimura, N ;
Tait, AD ;
Hughes, IA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) :658-665
[2]   DELETION OF STEROID 5-ALPHA-REDUCTASE 2-GENE IN MALE PSEUDOHERMAPHRODITISM [J].
ANDERSSON, S ;
BERMAN, DM ;
JENKINS, EP ;
RUSSELL, DW .
NATURE, 1991, 354 (6349) :159-161
[3]  
AUCHUS R J, 1989, Steroids, V53, P77, DOI 10.1016/0039-128X(89)90147-5
[4]   The enantiomer of progesterone (ent-progesterone) is a competitive inhibitor of human cytochromes P450c17 and P450c21 [J].
Auchus, RJ ;
Kumar, AS ;
Boswell, CA ;
Gupta, MK ;
Bruce, K ;
Rath, NP ;
Covey, DF .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 409 (01) :134-144
[5]   Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer [J].
Auchus, RJ ;
Lee, TC ;
Miller, WL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (06) :3158-3165
[6]   THE HUMAN CORPUS-LUTEUM SECRETES 5-ALPHA-PREGNANE-3,20-DIONE [J].
BACKSTROM, T ;
ANDERSSON, A ;
BAIRD, DT ;
SELSTAM, G .
ACTA ENDOCRINOLOGICA, 1986, 111 (01) :116-121
[7]   Expression cloning and characterization of oxidative 17 beta- and 3 alpha-hydroxysteroid dehydrogenases from rat and human prostate [J].
Biswas, MG ;
Russell, DW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (25) :15959-15966
[8]   Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase [J].
Bridges, A ;
Gruenke, L ;
Chang, YT ;
Vakser, IA ;
Loew, G ;
Waskell, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) :17036-17049
[9]  
BRUCHOVSKY N, 1968, J BIOL CHEM, V243, P2012
[10]   INCREASED TESTICULAR 5-ALPHA-ANDROSTANE-3-ALPHA, 17-BETA-DIOL FORMATION INDUCED BY TREATMENT WITH [D-SER(TBU)6, DES-GLY-NH210]LHRH ETHYLAMIDE IN THE RAT [J].
CARMICHAEL, R ;
BELANGER, A ;
CUSAN, L ;
SEGUIN, C ;
CARON, S ;
LABRIE, F .
STEROIDS, 1980, 36 (04) :383-391